Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
+5.92M
-
Total reported value, excl. options
-
$51.4M
-
Value change
-
+$23.1M
-
Number of buys
-
21
-
Number of sells
-
-3
-
Price
-
$4.01
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q1 2023
25 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q1 2023.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
.
Largest 10 shareholders include FMR LLC (2.9M shares), Cormorant Asset Management, LP (2.35M shares), FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.46M shares), Point72 Asset Management, L.P. (1.25M shares), MILLENNIUM MANAGEMENT LLC (1.05M shares), Prosight Management, LP (901K shares), Integral Health Asset Management, LLC (582K shares), VANGUARD GROUP INC (398K shares), and UBS OCONNOR LLC (230K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.